The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT)

Christian H. Geisler; Arne Kolstad; Anna Laurell; Riikka Raty; Mats Jerkeman; Mikael Eriksson; Marie Nordstrom; Eva Kimby; Anne Marie Boesen; Herman Nilsson-Ehle; Outi Kuittinen; Grete F. Lauritzsen; Elisabeth Ralfkiaer; Mats Ehinger; Christer Sundstrom; Jan Delabie; Marja-Liisa Karjalainen-Lindsberg; Peter Brown; Erkki Elonen; Nordic Lymphoma Grp

doi:10.1182/blood-2009-08-236570

The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT)

Christian H. Geisler, Arne Kolstad, Anna Laurell, Riikka Raty, Mats Jerkeman, Mikael Eriksson, Marie Nordstrom, Eva Kimby, Anne Marie Boesen, Herman Nilsson-Ehle, Outi Kuittinen, Grete F. Lauritzsen, Elisabeth Ralfkiaer, Mats Ehinger, Christer Sundstrom, Jan Delabie, Marja-Liisa Karjalainen-Lindsberg, Peter Brown, Erkki Elonen, Nordic Lymphoma Grp

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

Alkuperäiskieli	englanti
Lehti	Blood
Vuosikerta	115
Sivut	1530-1533
Sivumäärä	4
ISSN	0006-4971
DOI - pysyväislinkit	https://doi.org/10.1182/blood-2009-08-236570
Tila	Julkaistu - 2010
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

312 Kliiniset lääketieteet

Pääsy asiakirjaan

10.1182/blood-2009-08-236570

Siteeraa tätä

Geisler, C. H., Kolstad, A., Laurell, A., Raty, R., Jerkeman, M., Eriksson, M., Nordstrom, M., Kimby, E., Boesen, A. M., Nilsson-Ehle, H., Kuittinen, O., Lauritzsen, G. F., Ralfkiaer, E., Ehinger, M., Sundstrom, C., Delabie, J., Karjalainen-Lindsberg, M-L., Brown, P., Elonen, E., & Nordic Lymphoma Grp (2010). The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT). Blood, 115, 1530-1533. https://doi.org/10.1182/blood-2009-08-236570

@article{1b47874f986d4f96a6a2e548f66b52bb,

title = "The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT)",

keywords = "EUROPEAN-MCL-NETWORK, PROGRESSION-FREE SURVIVAL, NON-HODGKINS-LYMPHOMA, RITUXIMAB, THERAPY, RESCUE, MODEL, KI67, 312 Clinical medicine",

author = "Geisler, {Christian H.} and Arne Kolstad and Anna Laurell and Riikka Raty and Mats Jerkeman and Mikael Eriksson and Marie Nordstrom and Eva Kimby and Boesen, {Anne Marie} and Herman Nilsson-Ehle and Outi Kuittinen and Lauritzsen, {Grete F.} and Elisabeth Ralfkiaer and Mats Ehinger and Christer Sundstrom and Jan Delabie and Marja-Liisa Karjalainen-Lindsberg and Peter Brown and Erkki Elonen and {Nordic Lymphoma Grp}",

year = "2010",

doi = "10.1182/blood-2009-08-236570",

language = "English",

volume = "115",

pages = "1530--1533",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

}

Geisler, CH, Kolstad, A, Laurell, A, Raty, R, Jerkeman, M, Eriksson, M, Nordstrom, M, Kimby, E, Boesen, AM, Nilsson-Ehle, H, Kuittinen, O, Lauritzsen, GF, Ralfkiaer, E, Ehinger, M, Sundstrom, C, Delabie, J, Karjalainen-Lindsberg, M-L, Brown, P, Elonen, E & Nordic Lymphoma Grp 2010, 'The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT)', Blood, Vuosikerta 115, Sivut 1530-1533. https://doi.org/10.1182/blood-2009-08-236570

The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT). / Geisler, Christian H.; Kolstad, Arne; Laurell, Anna et al.

julkaisussa: Blood, Vuosikerta 115, 2010, s. 1530-1533.

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

TY - JOUR

T1 - The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT)

AU - Geisler, Christian H.

AU - Kolstad, Arne

AU - Laurell, Anna

AU - Raty, Riikka

AU - Jerkeman, Mats

AU - Eriksson, Mikael

AU - Nordstrom, Marie

AU - Kimby, Eva

AU - Boesen, Anne Marie

AU - Nilsson-Ehle, Herman

AU - Kuittinen, Outi

AU - Lauritzsen, Grete F.

AU - Ralfkiaer, Elisabeth

AU - Ehinger, Mats

AU - Sundstrom, Christer

AU - Delabie, Jan

AU - Karjalainen-Lindsberg, Marja-Liisa

AU - Brown, Peter

AU - Elonen, Erkki

AU - Nordic Lymphoma Grp

PY - 2010

Y1 - 2010

KW - EUROPEAN-MCL-NETWORK

KW - PROGRESSION-FREE SURVIVAL

KW - NON-HODGKINS-LYMPHOMA

KW - RITUXIMAB

KW - THERAPY

KW - RESCUE

KW - MODEL

KW - KI67

KW - 312 Clinical medicine

U2 - 10.1182/blood-2009-08-236570

DO - 10.1182/blood-2009-08-236570

M3 - Article

VL - 115

SP - 1530

EP - 1533

JO - Blood

JF - Blood

SN - 0006-4971

ER -

Geisler CH, Kolstad A, Laurell A, Raty R, Jerkeman M, Eriksson M et al. The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT). Blood. 2010;115:1530-1533. doi: 10.1182/blood-2009-08-236570